# FDA Inspection 1019092 - Biomat USA, Inc - July 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3cf6fb4a-558d-45cc-b8ff-5fdb16ac7252
Source feed: FDA_Inspections

> FDA Inspection 1019092 for Biomat USA, Inc on July 14, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1019092
- Company Name: Biomat USA, Inc
- Inspection Date: 2017-07-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1225670 - 2023-12-13](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/115b3de8-bdb5-4e59-b817-f1dab0d13553)
- [FDA Inspection 894511 - 2014-08-27](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/68d6fb44-8a42-48d7-a20c-56bc2aa884de)
- [FDA Inspection 731445 - 2011-06-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/4ec6bb65-faa5-4b9c-a39c-68057e232967)

Company: https://www.keypedia.com/companies/biomat-usa-inc/24b2fb53-15b0-4107-9db6-1ffaa12bba69

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d